490
Views
10
CrossRef citations to date
0
Altmetric
REVIEW

Salvage Treatment for Invasive Aspergillosis and Mucormycosis: Challenges, Recommendations and Future Considerations

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 2167-2178 | Received 18 Dec 2022, Accepted 23 Mar 2023, Published online: 12 Apr 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Johannes Boyer, Martin Hoenigl & Lisa Kriegl. (2024) Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?. Expert Review of Clinical Pharmacology 17:4, pages 309-321.
Read now

Articles from other publishers (9)

Kalyani Dhirendra Asgaonkar, Trupti Sameer Chitre, Shital Manoj Patil, Krishna Sambhajirao Shevate, Ashwini Kishan Sagar, Dipti Dattatray Ghate & Parth Anil Shah. (2024) Green Chemistry and In silico Techniques for Synthesis of Novel Pyranopyrazole and Pyrazolo-pyrano-pyrimidine Derivatives as Promising Antifungal Agents. Recent Advances in Anti-Infective Drug Discovery 19:3, pages 216-231.
Crossref
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, Roger Brüggemann, Agostinho Carvalho, Tom Chiller, Sharon Chen, Matthias Egger, Simon Feys, Jean-Pierre Gangneux, Jeremy A. W. Gold, Andreas H. Groll, Jannes Heylen, Jeffrey D. Jenks, Robert Krause, Katrien Lagrou, Frédéric Lamoth, Juergen Prattes, Sarah Sedik, Joost Wauters, Nathan P. Wiederhold & George R. ThompsonIIIIII. (2024) Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clinical Microbiology Reviews 37:2.
Crossref
Erhu Wei, Jiechao Niu, Mengjiao Zhang, Yu Zhang, Kunli Yan, Xiao Fang, Wei Ma, Lei Xie, Peisheng Jia & Huaili Wang. (2024) Metagenomic next-generation sequencing could play a pivotal role in validating the diagnosis of invasive mold disease of the central nervous system. Frontiers in Cellular and Infection Microbiology 14.
Crossref
Lisa Kriegl, Matthias Egger, Johannes Boyer, Martin Hoenigl & Robert Krause. (2024) New treatment options for critically important WHO fungal priority pathogens. Clinical Microbiology and Infection.
Crossref
Helmut J. F. Salzer. (2024) Antiinfektive Therapie von Pilzinfektionen durch Candida und AspergillusAnti-infective treatment of fungal infections by Candida and Aspergillus. Wiener klinisches Magazin 27:2, pages 46-53.
Crossref
L Shamithra M Sigera & David W Denning. (2024) A Systematic Review of the Therapeutic Outcome of Mucormycosis. Open Forum Infectious Diseases 11:1.
Crossref
George R. ThompsonIIIIII, Jeffrey D. Jenks, John W. Baddley, James S. LewisIIII, Matthias Egger, Ilan S. Schwartz, Johannes Boyer, Thomas F. Patterson, Sharon C.-A. Chen, Peter G. Pappas & Martin Hoenigl. (2023) Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management. Clinical Microbiology Reviews 36:3.
Crossref
Helmut J. F. Salzer. (2023) Antiinfektive Therapie von Pilzinfektionen durch Candida und AspergillusAnti-infective treatment of fungal infections by Candida and Aspergillus. Medizinische Klinik - Intensivmedizin und Notfallmedizin 118:6, pages 470-476.
Crossref
Anna Beltrame, David A. Stevens & Donna Haiduven. (2023) Mortality in ICU Patients with COVID-19-Associated Pulmonary Aspergillosis. Journal of Fungi 9:6, pages 689.
Crossref